Elevance Health
Q4 2022 Earnings Call
Jan 25, 2023, 8:30 a.m. ET
Contents:
- Prepared Remarks
- Questions and Answers
- Call Participants
Prepared Remarks:
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health fourth quarter earnings conference call. [Operator instructions] I would now like to turn the conference over to the company's management. Please go ahead.
Steve Tanal -- Vice President, Investor Relations
Good morning, and welcome to Elevance Health's fourth quarter 2022 earnings call. This is Steve Tanal, vice president of investor relations. And I am joined this morning on our earnings call by Gail Boudreaux, president and CEO; John Gallina, our CFO; Peter Haytaian, president of Carelon; Morgan Kendrick, president of our commercial and specialty business division; and Felicia Norwood, president of our government business division. Gail will begin the call with a brief discussion of some of the highlights of the quarter and year before turning to our recent announcement of the acquisition of Blue Cross and Blue Shield of Louisiana, and a number of other updates on key strategic initiatives.
John will then discuss our financial results and outlook for 2023 in greater detail. After our prepared remarks, the team will be available for Q&A. During the call, we will reference certain non-GAAP measures. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are available on our website, elevancehealth.com.
We will also be making some forward-looking statements on this call. Listeners are cautioned that these statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of Elevance Health. These risks and uncertainties can cause actual results to differ materially from our current expectations. We advise listeners to carefully review the risk factors discussed in today's press release and in our quarterly filings with the SEC.
I will now turn the call over to Gail.
Gail Boudreaux -- President and Chief Executive Officer
Thanks, Steve, and good morning, everyone. Today, we're pleased to share that Elevance Health delivered strong fourth quarter results, closing out another year of growth consistent with our long-term targets and considerable progress in our transformation to become a lifetime trusted health partner. In the fourth quarter, Elevance Health delivered GAAP earnings per share of $3.93 and adjusted earnings per share of $5.23. For the full year, we reported GAAP earnings per share of $24.81 and adjusted earnings per share of $29.07, reflecting growth of 15% year over year from our adjusted baseline of $25.20 in 2022.